Mast cell density and the context of clinicopathological parameters and expression of p185, estrogen receptor, and proliferating cell nuclear antigen in gastric carcinoma

World Journal of Gastroenterology

Volumn 8, Issue 6, 2002, Pages 1005-1008

  Jiang, Ying An ^a   Zhang, You Yuan ^b   Luo, He Sheng ^a   Xing, Shou Fu ^c  

^a WUHAN UNIVERSITY   (China)

^b Central Hospital of Huangshi   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; ESTROGEN RECEPTOR; PROTEIN P185;

ADULT; AGE; AGED; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER TISSUE; CELL COUNT; CELL DENSITY; CELL LABELING; CELL PROLIFERATION; CONTROLLED STUDY; GENERAL PATHOLOGICAL PARAMETERS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAST CELL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH CARCINOMA;

EID: 0036899184     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v8.i6.1005     Document Type: Article

References (37)

1. Tomita M, Matsuzaki Y, Edagawa M, Shimizu T, Hara M, Sekiya R, Onitsuka T. Association of mast cells with tumor angiogenesis in esophageal squamous cell carcinoma. Dis Esophagus 2001; 14: 135-138
2. Tomita M, Matsuzaki Y, Onitsuka T. Effect of mast cells on tumor angiogenesis in lung cancer. Ann Thorac Surg 2000; 69: 1686-1690
3. Erkilic S, Erbagci Z. The significance of mast cells associated with basal cell carcinoma. J Dermatol 2001; 28: 312-315
4. Terada T, Matsunaga Y. Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Hepatol 2000; 33: 961-966
5. Wilkins BS, Buchan SL, Webster J, Jones DB. Tryptase-positive mast cells accompany lymphocytic as well as lymphoplasmacytic lymphoma infiltrates in bone marrow trephine biopsies. Histopathology 2001; 39: 150-155
6. Hart PH, Grimbaldeston MA, Finlay-Jones JJ. Sunlight, immunosuppression and skin cancer: Role of histamine and mast cells. Clin Exp Pharmacol Physiol 2001; 28: 1-8
7. Terada T, Matsunaga Y. Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Hepatol 2000; 33: 961-966
8. Sawatsubashi M, Yamada T, Fukushima N, Mizokami H, Tokunaga O, Shin T. Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. Virchows Arch 2000; 436: 243-248
9. Johansson S, Landstrom M, Bjermer L, Henriksson R. Effects of tobacco smoke on tumor growth and radiation response of dunning R3327 prostate adenocarcinoma in rats. Prostate 2000; 42: 253-259
10. Takanami I, Takeuchi K, Naruke M. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 2000; 88: 2686-2692
11. Imada A, Shijubo N, Kojima H, Abe S. Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. Eur Respir J 2000; 15: 1087-1093
12. Tomita M, Matsuzaki Y, Onitsuka T. Correlation between mast cells and survival rates in patients with pulmonary adenocarcinoma. Lung Cancer 1999; 26: 103-108
13. Elpek GO, Gelen T, Aksoy NH, Erdogan A, Dertsiz L, Demircan A, Keles N. The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. J Clin Pathol 2001; 54: 940-944
14. Bowers HM Jr, Mahapatro RC, Kennedy JW. Numbers of mast cells in the axillary lymph nodes of breast cancer patients. Cancer 1979; 43: 568-573
15. Dabbous MK, Haney L, Nicolson GL, Eckley D, Woolley DE. Mast cell modulation of tumour cell proliferation in rat mammary adenocarcinoma 13762NF. Br J Cancer 1991; 63: 873-878
16. Hultsch T, Brand P, Lohmann S, Saloga J, Kincaid RL, Knop J. Direct evidence that FK506 inhibition of FcepsilonRI-mediated exocytosis from RBL mast cells involves calcineurin. Arch Dermatol Res 1998; 290: 258-263
17. Nakamura K, Tanaka T, Morita E, Kameyoshi Y, Yamamoto S. Enhancement of fibroblast-dependent mast cell growth in mice by a conditioned medium of keratinocyte-derived squamous cell carcinoma cells. Arch Dermatol Res 1994; 287: 91-96
18. Wang X, Ruan Y, Wu Z. Studies of mast cell-mediated cytotoxicity to hepatoma cells in vitro. Zhonghua Zhongliu Zazhi 1996; 18: 276-278
19. Xu Y, Guo Z. The number of lymph node with metastases influences survival in patients with cancer of the thoracic esophagus. Zhonghua Zhongliu Zazhi 2000; 22: 244-246
20. Roder JD, Bottcher K, Busch R, Wittekind C, Hermanek P, Siewert JR. Classification of regional lymph node metastasis from gastric carcinoma. German Gastric Cancer Study Group. Cancer 1998; 82: 621-631
21. Lanza G, Gafa R, Decarli N. Pathological factors involved in lymph node status determination in colorectal carcinoma: Analysis of 166 cases with long-term follow-up. Pathologica 2001; 93: 631-639
22. Nakajima Y, Nagai K, Miyake S, Ohashi K, Kawano T, Iwai T. Evaluation of an indicator for lymph node metastasis of esophageal squamous cell carcinoma invading the submucosal layer. Jpn J Cancer Res 2002; 93: 305-312
23. Wong JH, Steinemann S, Tom P, Morita S, Tauchi-Nishi P. Volume of lymphatic metastases does not independently influence prognosis in colorectal cancer. J Clin Oncol 2002; 20: 1506-1511
24. Rouzier R, Extra JM, Klijanienko J, Falcou MC, Asselain B, Vincent-Salomon A, Vielh P, Bourstyn E. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol 2002; 20: 1304-1310
25. Katai H, Maruyama K, Sasako M, Sano T. Incidence of nodal metastasis around the superior border of the pancrease based on number of metastatic perigastric nodes. Gastric Cancer 1998; 1: 115-117
26. Ichikura T, Morita D, Uchida T, Okura E, Majima T, Ogawa T, Mochizuki H. Sentinel node concept in gastric carcinoma. World J Surg 2002; 26: 318-322
27. Lau WK, Blute ML, Bostwick DG, Weaver AL, Sebo TJ, Zincke H. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: Differences in outcome between primary Gleason grades 3 and 4. J Urol 2001; 166: 1692-1697
28. Sasatomi E, Finkelstein SD, Woods JD, Bakker A, Swalsky PA, Luketich JD, Fernando HC, Yousem SA. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: Implications for the timing of lymph node metastasis and prognostic value. Cancer Res 2002; 62: 2681-2689
29. Niemann TH, Yilmaz AG, Marsh WL Jr, Lucas JG. A half a node or a whole node: A comparison of methods for submitting lymph nodes. Am J Clin Pathol 1998; 109: 571-576
30. Maurel J, Launoy G, Grosclaude P, Gignoux M, Arveux P, Mathieu-Daude H, Raverdy N, Faivre J. Lymph node harvest reporting in patients with carcinoma of the large bowel: A French population-based study. Cancer 1998; 82: 1482-1486
31. Dursun A, Poyraz A, Celik B, Akyol G. Expression of c-erbB-2 oncoprotein in gastric carcinoma: Correlation with histopathologic characteristics and analysis of Ki-67. Pathol Oncol Res 1999; 5: 104-106
32. Aoyagi K, Kohfuji K, Yano S, Murakami N, Miyagi M, Takeda J, Shirouzu K. Evaluation of the epidermal growth factor receptor (EGFR) and c-erbB-2 in superspreading-type and penetrating-type gastric carcinoma. Kurume Med J 2001; 48: 197-200
33. Oshima CT, Lanzoni VP, Iriya K, Forones NM. C-erbB-2 oncoprotein in gastric carcinoma: Correlation with clinical stage and prognosis. Int J Biol Markers 2001; 16: 250-254
34. Xin Y, Li XL, Wang YP, Zhang SM, Zheng HC, Wu DY, Zhang YC. Relationship between phenotypes of cell-function differentiation and pathobiological behavior of gastric carcinomas. World J Gastroenterol 2001; 7: 53-59
35. Noda H, Maehara Y, Irie K, Kakeji Y, Yonemura T, Sugimachi K. Increased proliferative activity caused by loss of p21(WAF1/CIP1) expression and its clinical significance in patients with early-stage gastric carcinoma. Cancer 2002; 94: 2107-2112
36. Tao K, Chen D, Tian Y, Lu X, Yang X. The relationship between apoptosis and the expression of proliferating cell nuclear antigen and the clinical stages in gastric carcinoma. J Tongji Med Univ 2000; 20: 222-224
37. Konno S, Takebayashi Y, Aiba M, Akiyama S, Ogawa K. Clinicopathological and prognostic significance of thymidine phosphorylase and proliferating cell nuclear antigen in gastric carcinoma. Cancer Lett 2001; 166: 103-111